These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38078567)

  • 1. Hemostatic balance between pro- and anticoagulant is maintained during glucocorticoid treatment.
    Yamashita A; Nagae C; Umezawa Y; Mori M; Ashikaga T; Akita M; Suzuki N; Yamazaki S; Takayama S; Taki M
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30812. PubMed ID: 38078567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.
    Tripodi A
    Thromb Haemost; 2017 May; 117(5):830-836. PubMed ID: 28229158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation.
    Habib M; Roberts LN; Patel RK; Wendon J; Bernal W; Arya R
    Liver Int; 2014 May; 34(5):672-8. PubMed ID: 24164805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
    Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
    Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Normal" thrombin generation.
    Butenas S; van't Veer C; Mann KG
    Blood; 1999 Oct; 94(7):2169-78. PubMed ID: 10498586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors.
    Tripodi A; Ammollo CT; Semeraro F; Colucci M; Malchiodi E; Verrua E; Ferrante E; Arnaldi G; Trementino L; Padovan L; Chantarangkul V; Peyvandi F; Mantovani G
    Endocrine; 2017 May; 56(2):298-307. PubMed ID: 27448294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests.
    Lisman T; Bakhtiari K; Pereboom IT; Hendriks HG; Meijers JC; Porte RJ
    J Hepatol; 2010 Mar; 52(3):355-61. PubMed ID: 20132999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
    Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Hartl L; Jachs M; Bauer D; Stättermayer AF; Semmler G; Pinter M; Ay C; Quehenberger P; Trauner M; Reiberger T; Lisman T; Mandorfer M
    J Hepatol; 2022 May; 76(5):1090-1099. PubMed ID: 35066090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications.
    Kim HK; Kim JE; Park SH; Kim YI; Nam-Goong IS; Kim ES
    J Diabetes Complications; 2014; 28(3):365-9. PubMed ID: 24560421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between coagulation disorders and the risk of bleeding in cirrhotic patients.
    Labidi A; Baccouche H; Fekih M; Mahjoub S; BenMustapha N; Serghini M; BenRomdhane N; Boubaker J
    Ann Hepatol; 2019; 18(4):627-632. PubMed ID: 31097395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostatic balance in cirrhosis.
    Baccouche H; Labidi A; Fekih M; Mahjoub S; Kaabi H; Hmida S; Filali A; Romdhane NB
    Blood Coagul Fibrinolysis; 2017 Mar; 28(2):139-144. PubMed ID: 27182688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
    Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
    Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma.
    Cvirn G; Gallistl S; Rehak T; Jürgens G; Muntean W
    J Thromb Haemost; 2003 Aug; 1(8):1785-90. PubMed ID: 12911594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.
    Tripodi A; Primignani M; Lemma L; Chantarangkul V; Mannucci PM
    J Hepatol; 2013 Aug; 59(2):265-70. PubMed ID: 23583273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections.
    Zanetto A; Campello E; Bulato C; Gavasso S; Saggiorato G; Shalaby S; Burra P; Angeli P; Senzolo M; Simioni P
    JHEP Rep; 2022 Jul; 4(7):100493. PubMed ID: 35647501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation Factor Levels and Underlying Thrombin Generation Patterns in Adult Extracorporeal Membrane Oxygenation Patients.
    Mazzeffi M; Strauss E; Meyer M; Hasan S; Judd M; Abuelkasem E; Chow J; Nandwani V; McCarthy P; Tanaka K
    Anesth Analg; 2019 Sep; 129(3):659-666. PubMed ID: 31425204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis.
    Sinegre T; Duron C; Lecompte T; Pereira B; Massoulier S; Lamblin G; Abergel A; Lebreton A
    J Thromb Haemost; 2018 Jun; 16(6):1132-1140. PubMed ID: 29577605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein augments the anticoagulant function of the protein C system in thrombin generation.
    Wan J; Vadaq N; Konings J; Jaeger M; Kumar V; de Laat B; Joosten L; Netea MG; van der Ven AJ; de Groot PG; de Mast Q; Roest M
    J Thromb Haemost; 2022 Jan; 20(1):48-57. PubMed ID: 34532976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients.
    Schöchl H; Voelckel W; Maegele M; Kirchmair L; Schlimp CJ
    Crit Care; 2014 Jul; 18(4):R147. PubMed ID: 25008277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.